Paradigm Shift in the Management of Clostridioides difficile Infections
Public Health Watch: Moderna Vaccine May Cause More Reactions, Higher Antibody Response
Study comparing mRNA shots finds variability in response, though both generally safe and effective.
Football Games with Limited Attendance Not Associated with COVID-19 Spread
Attendance of professional and college football games may resume with COVID-19 mitigation measures, according to a study that found no association between games with limited attendance and COVID-19 cases.
Will an FDA-Approved COVID-19 Vaccine Convince People to Get the Shot?
David Weber, MD, MPH, explains what portion of the population may buy into the newly approved Pfizer-BioNTech vaccine.
Children, COVID-19, and Another Crazy Respiratory Viral Season
Kevin J. Downes, MD, and Contagion® Section Editor Conan MacDougall, PharmD, MAS, BCPS, BCIDP, discuss these important topics as another season approaches.
Former FDA Commissioner Expects More Vaccine Mandates
With the full FDA approval of the Pfizer-BioNTech COVID-19 vaccine, Mark McClellan, MD, PhD, says more employer mandates will likely be coming, but he does not see federal government intervention in this area.
CDC Says Serious Adverse Events Remain ‘Rare’ Following COVID-19 Vaccination
The most common adverse event was myocarditis, which was reported in nearly 500 patients. None of those patients had died as of the new analysis, and the rate per million cases was 3.5 cases.
FDA Approves Pfizer-BioNTech COVID-19 Vaccine
The full approval for BNT162b2 will afford physicians greater prescribing capability, and will likely drive workplace vaccine mandates.
Daptomycin as Frontline Therapy for MRSA Bacteremia: Has the Time Come?
Findings increasingly suggest the mortality risk may be reduced by initiating daptomycin within 3 days of infection.
The Potential Addition of Long-Acting Injectables for PrEP
What does this form of pre-exposure prophylaxis (PrEP) mean in terms of options and initiation.
FDA Approval on Pfizer-BioNTech COVID-19 Vaccine May Come Monday
The decision on the final federal approval in the US could mean many more people would get the vaccine.
WHO will Test 3 Additional Drugs Repurposed to Treat COVID-19
The World Health Organization (WHO) announces the Solidarity PLUS platform trial of drugs repurposed to treat COVID-19 after Solidarity trial candidates disappoint.
Early Vaccine Campaign in United States Prevented Deaths
The study was supported by the National Institutes on Aging.
Short COVID-19 Hospitals Stays May Results in Long-Term Health and Financial Impacts
One of the major risk factors was a lack of follow-up healthcare services.
Those With Severe COVID-19 Have High Levels of Important Antibody
IgG titers were positively linked with symptom severity and certain comorbidities.
A Plan for Booster Doses, Pediatric Hospitalizations Rates Going Up
The US federal government announces plans for mRNA COVID-19 vaccine booster doses, and more children and teens are getting hospitalized for the virus.
The Variety of Variants in COVID-19
The evolution of the major variants, including the delta mutation.
Providing Free PrEP to MSM and Trans Individuals in a Community Setting
HIV risk perception and concern regarding HIV infection declined during the study.
Better Face Masks, Ventilation Mitigates Spread of COVID-19
Common cloth and surgical masks allow for the build-up of aerosol droplets over time.
Examining the HIV Treatment Pipeline
A review of selected investigational long-active treatment options for HIV.
Preventing a Candida Auris Outbreak in the Health Care Setting
Infection preventionists at UCLA used active surveillance screening and technology to take a proactive approach to staving off any potential outbreaks of the emerging fungal infection in their health system.
CoronaVac COVID-19 Vaccine Linked With Increased Risk of Bell’s Palsy
While an association was found, the adverse events are very rare.
CAB-LA Superior HIV Prevention to TDF–FTC in MSM
Long acting injectable PrEP therapies that are safe and effective are needed to increase options for at-risk individuals.
US to Begin Offering COVID-19 Booster Shots Starting September 20
All Americans who received either Pfizer or Moderna will be eligible 8 months after their second dose.
Creating Greater PrEP Access with Large Public Health Goals and Local Service Models
Macro and micro strategies are at play in aiming to create greater PrEP access and adoption.
Ibrexafungerp: A Novel Antifungal Agent That Is Easier to Pronounce Than Spell
How Has COVID-19 Impacted PrEP Care in the LGBTQ Community?
PrEP initiations, discontinuations and lapses all increased among Latinx patients post shelter-in-place orders.
Mono or Combo? Exploring the Role of Combination Antimicrobial Therapies for Invasive Carbapenem-Resistant Gram-Negative Infections
CDC Announces Shrimp Salmonella Outbreak
The federal agency identified 3 more illnesses and the shrimp supplier expanded their recall.
US Wants COVID-19 Vaccine Booster Doses at 8 Months
The Biden administration reportedly hopes for FDA-authorized booster doses for the adult general population in the next month.